Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuqi Jiang

Showing results (71-80 of 135) with videos related to

Pageof 14
Sort By:
ACS Chemical Neuroscience|June 28, 2017
Development and Characterization of a Hydroxyl-Sulfonamide Analogue, 5-Chloro-N-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide, as a Novel NLRP3 Inflammasome Inhibitor for Potential Treatment of Multiple SclerosisChunqing Guo, Jacob W Fulp, Yuqi Jiang, et al.
Journal of Visualized Experiments : Jove|February 17, 2025
Mixed Reality Assisted Radical Endoscopic ThyroidectomyPeng Zhang, Yifan Ke, Jiezhong Wu, et al.
Journal of Clinical Nursing|March 25, 2022
Post-discharge care needs of the older people with hospital-associated disability: A longitudinal studyZhiqin Yin, Yisha Ying, Xiuyue Li, et al.
BMC Medical Education|May 29, 2026
Benefit of mixed reality assistance on CT-based ear anatomy spatial recognition: a preliminary studyJia Guo, Jianguo Duan, Yandi He, et al.
Journal of Medicinal Chemistry|April 4, 2014
Discovery of the first N-hydroxycinnamamide-based histone deacetylase 1/3 dual inhibitors with potent oral antitumor activityXiaoyang Li, Elizabeth S Inks, Xiaoguang Li, et al.
Journal of Medicinal Chemistry|March 3, 2023
Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of GemcitabineLiang Zhang, Kangjing Qi, Jie Xu, et al.
Journal of Medicinal Chemistry|November 11, 2025
Design, Synthesis, and Anti-inflammatory Activity Evaluation for Hydrazide-Based HDAC6 Targeted Protein DegradersSimin Sun, Kairui Yue, Enqiang Liu, et al.
Disability and Rehabilitation|January 4, 2023
Cross-cultural adaptation and validation of the positive and negative social exchange scale in older adults with disabilities in ChinaYuqi Jiang, Chuncong Zhou, Lijuan Zhu, et al.
Medical Oncology (Northwood, London, England)|June 3, 2025
Antitumor effect of BC12-3 on multiple myeloma via proteasome inhibitionHuiying Li, Geng Jia, Naixin Zhang, et al.
European Journal of Medicinal Chemistry|December 5, 2017
Synthesis and biological characterization of ubenimex-fluorouracil conjugates for anti-cancer therapyYuqi Jiang, Xiaoyang Li, Jinning Hou, et al.
Pageof 14

Showing results (71-80 of 135) with videos related to

Sort By:
Pageof 14
ACS Chemical Neuroscience|June 28, 2017
Development and Characterization of a Hydroxyl-Sulfonamide Analogue, 5-Chloro-N-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide, as a Novel NLRP3 Inflammasome Inhibitor for Potential Treatment of Multiple SclerosisChunqing Guo, Jacob W Fulp, Yuqi Jiang, et al.
Journal of Visualized Experiments : Jove|February 17, 2025
Mixed Reality Assisted Radical Endoscopic ThyroidectomyPeng Zhang, Yifan Ke, Jiezhong Wu, et al.
Journal of Clinical Nursing|March 25, 2022
Post-discharge care needs of the older people with hospital-associated disability: A longitudinal studyZhiqin Yin, Yisha Ying, Xiuyue Li, et al.
BMC Medical Education|May 29, 2026
Benefit of mixed reality assistance on CT-based ear anatomy spatial recognition: a preliminary studyJia Guo, Jianguo Duan, Yandi He, et al.
Journal of Medicinal Chemistry|April 4, 2014
Discovery of the first N-hydroxycinnamamide-based histone deacetylase 1/3 dual inhibitors with potent oral antitumor activityXiaoyang Li, Elizabeth S Inks, Xiaoguang Li, et al.
Journal of Medicinal Chemistry|March 3, 2023
Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of GemcitabineLiang Zhang, Kangjing Qi, Jie Xu, et al.
Journal of Medicinal Chemistry|November 11, 2025
Design, Synthesis, and Anti-inflammatory Activity Evaluation for Hydrazide-Based HDAC6 Targeted Protein DegradersSimin Sun, Kairui Yue, Enqiang Liu, et al.
Disability and Rehabilitation|January 4, 2023
Cross-cultural adaptation and validation of the positive and negative social exchange scale in older adults with disabilities in ChinaYuqi Jiang, Chuncong Zhou, Lijuan Zhu, et al.
Medical Oncology (Northwood, London, England)|June 3, 2025
Antitumor effect of BC12-3 on multiple myeloma via proteasome inhibitionHuiying Li, Geng Jia, Naixin Zhang, et al.
European Journal of Medicinal Chemistry|December 5, 2017
Synthesis and biological characterization of ubenimex-fluorouracil conjugates for anti-cancer therapyYuqi Jiang, Xiaoyang Li, Jinning Hou, et al.
Pageof 14